Polynovo Ltd
Research Polynovo Ltd (MFJ) on Bullrun: market cap EUR 392.42M, P/E 55.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMFJ
- ExchangeF
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 392.42M
- P/E55.0
- Financial periodFY2025
- RevenueAUD 127.24M
- Revenue growth23.3%
- Net incomeAUD 13.21M
- Free cash flow-AUD 10.78M
- Gross margin95.9%
Valuation Snapshot
latest market cap is EUR 392.42M; P/E is 55.0.
Peer valuation comparison
Latest P/E is 55x versus a Healthcare sector median of 24.46x (124.9% above).
Latest P/E is 55x versus a Australia median of 16.97x (224.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 127.24M | AUD 13.21M | -AUD 10.78M | 95.9% | 0.02 | AUD 33.54M | AUD 17.14M | AUD 83.26M |
| FY2024 | AUD 103.19M | AUD 5.26M | AUD 786.00K | 94.7% | 0.01 | AUD 45.91M | AUD 15.38M | AUD 72.12M |
| FY2023 | AUD 65.24M | -AUD 4.92M | -AUD 8.14M | 93.2% | -0.01 | AUD 46.85M | AUD 16.04M | AUD 65.38M |
| FY2022 | AUD 41.44M | -AUD 1.19M | -AUD 2.55M | 94.7% | 0 | AUD 6.10M | AUD 10.99M | AUD 17.72M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 392.42M | 55.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Polynovo Ltd's market cap?
Polynovo Ltd's market capitalization is EUR 392.42M.
What is Polynovo Ltd's P/E ratio?
Polynovo Ltd's price-to-earnings (P/E) ratio is 55.0.
What does Polynovo Ltd do?
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn.